| NCT02749474 |
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes |
| NCT05111561 |
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer |
| NCT04947254 |
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer |
| NCT04666727 |
Role of Diet on the Microbiome of the Digestive System |
| NCT07816666 |
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer |
| NCT07391956 |
Tier Palliative Care For Patients With Advanced Heart Failure or Cancer |
| NCT07140172 |
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery |
| NCT07567027 |
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR) |
| NCT07226986 |
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC |
| NCT00898131 |
Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer |
| NCT07796061 |
Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT) |
| NCT07028853 |
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. |
| NCT06600906 |
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer |
| NCT07320664 |
Breast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women |
| NCT06463028 |
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer |
| NCT07848828 |
Autonomic and Renal Contributions to Hypertension With ADT |
| NCT06675136 |
Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases |
| NCT06244004 |
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial |
| NCT05753306 |
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study |
| NCT04606914 |
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
| NCT04073706 |
Sentinel Node Biopsy in Endometrial Cancer |
| NCT06095089 |
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer |
| NCT04594187 |
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma |
| NCT06686043 |
HPV Vaccine, Imiquimod, and Metformin Combination Trial |
| NCT02000089 |
The Cancer of the Pancreas Screening-5 CAPS5)Study |
| NCT04362826 |
Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer |
| NCT06353321 |
Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1 |
| NCT06798558 |
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy |
| NCT05797168 |
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors |
| NCT06553885 |
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC |
| NCT04692675 |
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer |
| NCT04550845 |
Understanding of Genetics by Men at Risk for Prostate Cancer |
| NCT07029399 |
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors |
| NCT07307664 |
Increasing Germline Genetic Testing for Patients With Cancer |
| NCT05435495 |
Mechanisms of Resistance to PSMA Radioligand Therapy |
| NCT07223411 |
Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma |
| NCT06092892 |
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases |
| NCT06149481 |
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) |
| NCT04965064 |
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling |
| NCT06910657 |
IDOV-Immune for Advanced Solid Tumors |
| NCT06270043 |
Focal Therapy for Localized Prostate Cancer |
| NCT05748834 |
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer |
| NCT05612347 |
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps |
| NCT06085833 |
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions |
| NCT07224464 |
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. |
| NCT07482384 |
Supporting Health Including Endocrine Treatment for Long Duration |
| NCT07332455 |
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC |
| NCT07137416 |
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer |
| NCT05035836 |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
| NCT07549958 |
PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) |
| NCT07548164 |
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer |
| NCT05595499 |
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors |
| NCT07158021 |
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial |
| NCT06817226 |
BREAST Choice Decision Tool R21 - AIM2 |
| NCT03604315 |
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF |
| NCT03567889 |
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients |
| NCT05979610 |
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies |
| NCT06371768 |
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors |
| NCT07594015 |
Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance |
| NCT07845617 |
Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma |
| NCT07454642 |
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors |
| NCT04402151 |
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer |
| NCT06252545 |
Promoting CT Engagement for Pancreatic Cancer With App |
| NCT06788886 |
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases |
| NCT06657222 |
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors |
| NCT04923542 |
SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases |
| NCT07073794 |
Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer |
| NCT07522073 |
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT06472661 |
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma |
| NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
| NCT06545604 |
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer |
| NCT06039085 |
Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment |
| NCT06582017 |
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma |
| NCT01416714 |
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy |
| NCT06953089 |
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors |
| NCT06534918 |
Precise Oncology Interventions in Nutrition and Training (OnPoint) |
| NCT04916990 |
Improving Care for Rural Patients With Solid Tumors |
| NCT05677490 |
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma |
| NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
| NCT05372640 |
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors |
| NCT05879913 |
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT |
| NCT06893276 |
e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients |
| NCT06529523 |
Tislelizumab in People With Colorectal Cancer |
| NCT07644559 |
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer |
| NCT05590624 |
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer |
| NCT06349590 |
Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery |
| NCT07721259 |
A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden |
| NCT06922591 |
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients |
| NCT05559879 |
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma |
| NCT07124351 |
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) |
| NCT06398639 |
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer |
| NCT06675357 |
Using FAPI PET/MRI to Evaluate Prostate Cancer |
| NCT05174286 |
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk |
| NCT06202183 |
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial |
| NCT03941756 |
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma |
| NCT07756281 |
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer |
| NCT07542041 |
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens |
| NCT03972657 |
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors |
| NCT04923178 |
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies |
| NCT07664735 |
A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer. |
| NCT05327608 |
Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery |
| NCT06190899 |
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer |
| NCT03382158 |
International PPB/DICER1 Registry |
| NCT06726148 |
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors |
| NCT06867484 |
Breast Re-irradiation After Second Ipsilateral Lumpectomy |
| NCT07325721 |
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer |
| NCT05939414 |
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. |
| NCT07764133 |
Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer |
| NCT06340568 |
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer |
| NCT07223385 |
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe) |
| NCT07733674 |
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC) |
| NCT07391774 |
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial |
| NCT07087691 |
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance |
| NCT06576115 |
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer |
| NCT07197723 |
Study of How People Make Decisions About Prostate Cancer Risk |
| NCT06298734 |
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial |
| NCT06083844 |
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy |
| NCT07341503 |
The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients |
| NCT06062745 |
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT |
| NCT05852041 |
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance |
| NCT06315595 |
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI |
| NCT07339176 |
Intratumoral N17350 in Advanced Solid Tumors |
| NCT07629960 |
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations |
| NCT07226856 |
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma |
| NCT06833866 |
Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer |
| NCT01530373 |
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients |
| NCT05497531 |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers |
| NCT04332588 |
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI |
| NCT07382583 |
Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer |
| NCT06219941 |
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 |
| NCT07174336 |
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) |
| NCT06518057 |
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer |
| NCT06305312 |
Community Services Navigation to Advance Health Equity in Breast Cancer Screening |
| NCT07698314 |
A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer |
| NCT06887348 |
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3 |
| NCT06943521 |
A Study of MT-4561 in Patients With Various Advanced Solid Tumors |
| NCT07192614 |
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer |
| NCT04003038 |
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery |
| NCT00034216 |
Collection of Blood From Patients With Cancer |
| NCT07224009 |
Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT) |
| NCT06272864 |
BostonGene and Exigent Genomic INsight Study |
| NCT07009093 |
Utility of a Mobile Application for Young Women With Breast Cancer |
| NCT01050504 |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
| NCT07219147 |
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| NCT07729150 |
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes |
| NCT04119024 |
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors |
| NCT07364474 |
Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver |
| NCT06026410 |
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors |
| NCT06398418 |
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors |
| NCT06835569 |
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations |
| NCT06185205 |
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy |
| NCT04294927 |
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention |
| NCT07910383 |
The Use of Contrast Enhanced Ultrasound (CEUS) In Post-Surgical Pancreatic Cancer Patients to Evaluate Local Disease Recurrence |
| NCT06672497 |
Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients |
| NCT03474913 |
Upright MRI for Prostate Cancer Screening |
| NCT03492424 |
Ablative Therapy in the Management of Prostate Cancer |
| NCT07767474 |
A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors |
| NCT04796818 |
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response |
| NCT06492759 |
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer |
| NCT07321106 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer |
| NCT06681233 |
Feasibility Study of CBCT for IGRT in Cancer Patients |
| NCT04486352 |
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer |
| NCT04893109 |
ATEMPT 2.0: Adjuvant T-DM1 vs TH |
| NCT04852887 |
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) |
| NCT05780814 |
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer |
| NCT05787834 |
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer |
| NCT06103864 |
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05) |
| NCT07677267 |
A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan |
| NCT05691465 |
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells |
| NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
| NCT06059118 |
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer |
| NCT06926868 |
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) |
| NCT06696768 |
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer |
| NCT05429970 |
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) |
| NCT07740941 |
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma |
| NCT07899151 |
Decision Support for Chemoprevention |
| NCT07718854 |
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer |
| NCT03539822 |
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies |
| NCT06593431 |
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial |
| NCT06330805 |
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer |
| NCT05037825 |
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors |
| NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
| NCT07011576 |
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL) |
| NCT02918474 |
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer |
| NCT07441889 |
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006) |
| NCT06945315 |
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS) |
| NCT07085091 |
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors |
| NCT07049276 |
The Multicentre Selective Lymphadenectomy Trial - 3 |
| NCT05766891 |
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery |
| NCT04991948 |
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer |
| NCT07443943 |
A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial |
| NCT06534125 |
Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer |
| NCT07182149 |
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors |
| NCT07221149 |
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) |
| NCT05372614 |
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene |
| NCT06532006 |
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer |
| NCT05178498 |
Impact of Dietary Inflammatory Potential on Breast Cancer Risk |
| NCT06290193 |
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery |
| NCT03053193 |
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles |
| NCT06246916 |
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) |
| NCT04816006 |
Breast Cancer, Reasoning, and Activity Intervention |
| NCT07822399 |
A Study of MGC030 in Participants With Advanced Solid Tumors |
| NCT07020806 |
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC) |
| NCT07466498 |
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial |
| NCT07862582 |
RYZ711 Diagnostic Platform Study |
| NCT07723651 |
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC) |
| NCT06925724 |
A Study of Ivonescimab in People With Endometrial and Cervical Cancers |
| NCT02830724 |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
| NCT07335224 |
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture |
| NCT04986423 |
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer |
| NCT05761561 |
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer |
| NCT06049355 |
EMBRACE: Exercising Together |
| NCT04899908 |
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases |
| NCT05608252 |
VS-6766+Abema+Fulv in Met HR+/HER- BC |
| NCT05534438 |
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer |
| NCT06524973 |
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers |
| NCT06037954 |
A Study of Mental Health Care in People With Cancer |
| NCT05103683 |
First in Human Study of TORL-1-23 in Participants With Advanced Cancer |
| NCT04763980 |
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer |
| NCT07807345 |
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic |
| NCT06863272 |
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) |
| NCT07319195 |
Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) |
| NCT07409272 |
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer |
| NCT04693377 |
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial |
| NCT04888975 |
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery |
| NCT03675893 |
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer |
| NCT06555133 |
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC |
| NCT07076147 |
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer |
| NCT04633252 |
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer |
| NCT04520139 |
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT |
| NCT05588453 |
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain |
| NCT05256745 |
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer |
| NCT06005493 |
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors |
| NCT06445738 |
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE) |
| NCT06383026 |
Individuals on Hormone Therapy Breast Cancer Screening Pilot |
| NCT05548296 |
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma |
| NCT05824975 |
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) |
| NCT06400563 |
MRg-NIRS Imaging System Breast Cancer Trial |
| NCT06377852 |
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study |
| NCT07869355 |
BRE-13: Mediterranean Diet |
| NCT06370143 |
A Study Collecting Health Information to Understand and Prevent Gastric Cancer |
| NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
| NCT06099093 |
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan |
| NCT05975593 |
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial |
| NCT06216938 |
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis |
| NCT04590326 |
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab |
| NCT06488378 |
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer |
| NCT05412225 |
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer |
| NCT07357298 |
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer |
| NCT05042687 |
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer |
| NCT06105684 |
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer |
| NCT07033026 |
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia. |
| NCT07287150 |
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT06476808 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. |
| NCT04959474 |
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer |
| NCT05679674 |
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer |
| NCT06934538 |
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer |
| NCT04589468 |
Researching the Effect of Exercise on Cancer |
| NCT06763432 |
Positive Fit to Colonoscopy: Closing the Gap |
| NCT07463833 |
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology |
| NCT07595874 |
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 |
| NCT06824818 |
Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients |
| NCT07817147 |
CREO - Microwave Ablation Feasibility Study |
| NCT07202247 |
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial |
| NCT07635147 |
Decision Support Tool for Patients With Advanced Breast Cancer |
| NCT07702032 |
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1) |
| NCT06567314 |
Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma |
| NCT07360119 |
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors |
| NCT04674267 |
Resilience and Equity in Aging, Cancer, and Health (REACH) |
| NCT07705334 |
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors |
| NCT04469764 |
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer |
| NCT04603209 |
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer |
| NCT07478016 |
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients |
| NCT07781800 |
Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health |
| NCT04706663 |
Precision-Based Genomics in Prostate Cancer |
| NCT06760819 |
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) |
| NCT06395519 |
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies |
| NCT07755436 |
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. |
| NCT06298916 |
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer |
| NCT07285057 |
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance |
| NCT05155033 |
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma |
| NCT07276438 |
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial |
| NCT06246968 |
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer |
| NCT06507618 |
Pre-Operative Window of ET to Inform RT Decisions (POWER II) |
| NCT06904378 |
ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT06636682 |
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer |
| NCT05464810 |
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer |
| NCT06136624 |
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) |
| NCT06400550 |
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis |
| NCT06595160 |
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy |
| NCT03250078 |
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals |
| NCT06815497 |
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer |
| NCT06860815 |
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer |
| NCT05313191 |
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors |
| NCT03334708 |
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma |
| NCT05107674 |
A Study of NX-1607 in Adults With Advanced Malignancies |
| NCT06949410 |
HER2 Vaccine for Locally Advanced Breast Cancer |
| NCT06545682 |
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) |
| NCT04775355 |
Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer |
| NCT02526368 |
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer |
| NCT06648278 |
Patient Care Outreach, Navigation, Technology and Support 2.0 |
| NCT07627191 |
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer |
| NCT04548817 |
Neurocutaneous Melanocytosis Registry |
| NCT05997017 |
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer |
| NCT07216560 |
First-in-human Study of 7MW4911 in GI Cancer |
| NCT07550517 |
PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT |
| NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma |
| NCT04434040 |
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) |
| NCT03711890 |
Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer |
| NCT07221825 |
Low-Count Quantitative SPECT for Men Treated With Radium-223 |
| NCT07203378 |
Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu |
| NCT06959550 |
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer |
| NCT00588185 |
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer |
| NCT07544589 |
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers |
| NCT07224750 |
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer |
| NCT06131840 |
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors |
| NCT06615752 |
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients |
| NCT07086833 |
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities |
| NCT07106359 |
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome |
| NCT04134780 |
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response |
| NCT02393703 |
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer |
| NCT07271017 |
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe |
| NCT07186296 |
EXoPERT EMERALD Clinical Study |
| NCT05546827 |
Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma |
| NCT07128927 |
Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors |
| NCT07223424 |
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy |
| NCT06340620 |
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope |
| NCT07064018 |
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies |
| NCT06974110 |
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors |
| NCT04907643 |
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
| NCT07014618 |
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer |
| NCT05291507 |
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System |
| NCT05321134 |
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery |
| NCT06374459 |
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis |
| NCT06662786 |
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer |
| NCT06923527 |
Circulating Tumor DNA |
| NCT07270666 |
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer |
| NCT07225270 |
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy |
| NCT07481383 |
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer |
| NCT07043270 |
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC |
| NCT06555588 |
Engage Psychosocial Intervention for Cancer Symptoms |
| NCT06861088 |
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer |
| NCT06660420 |
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel) |
| NCT05660083 |
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) |
| NCT07701941 |
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer |
| NCT07827573 |
A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment |
| NCT05633654 |
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) |
| NCT07619079 |
Malignant Polyp Registry |
| NCT07801664 |
Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer |
| NCT06526299 |
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease |
| NCT07895498 |
A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer |
| NCT06369285 |
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer |
| NCT07594106 |
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma |
| NCT07225114 |
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging |
| NCT03861676 |
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT |
| NCT05719558 |
A Study of ASP1002 in Adults for Treatment of Solid Tumors |
| NCT07293585 |
Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment |
| NCT04354064 |
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors |
| NCT04022616 |
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
| NCT03943316 |
Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer |
| NCT05125016 |
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer |
| NCT07032584 |
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer |
| NCT06760507 |
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics |
| NCT06295965 |
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study |
| NCT07048314 |
Stem Cells for Erectile Dysfunction Post RALP |
| NCT07525206 |
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer |
| NCT05840484 |
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance |
| NCT07219238 |
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) |
| NCT07463599 |
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma |
| NCT06342401 |
Early Onset Colorectal Cancer Detection |
| NCT04924075 |
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) |
| NCT06040541 |
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors |
| NCT05051722 |
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer |
| NCT04545957 |
Jump: MR Simulation For Radiation Therapy Master Protocol |
| NCT07173257 |
PROMs After Pancreatectomy |
| NCT04692818 |
3D Ultrasound Breast Imaging |
| NCT07231627 |
AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions |
| NCT06499870 |
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial |
| NCT06378866 |
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial |
| NCT05478694 |
Outcomes of Focal Ablation for Prostate Cancer |
| NCT06864754 |
WashU DIEP Flap Video and Patient Understanding Improvement |
| NCT05001477 |
Customized TULSA-PRO Ablation Registry |
| NCT05985954 |
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy |
| NCT07164456 |
Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers |
| NCT05379595 |
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer |
| NCT07332000 |
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec |
| NCT06820463 |
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer |
| NCT06392295 |
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer |
| NCT05914116 |
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors |
| NCT07654257 |
Single FrAction Interstitial BreaSt BracHytherApy |
| NCT04214119 |
EsophaCap for the Detection of Early Esophageal Carcinoma |
| NCT06138067 |
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients |
| NCT00477100 |
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer |
| NCT06902311 |
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) |
| NCT06330064 |
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) |
| NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer |
| NCT07220967 |
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement |
| NCT05043012 |
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) |
| NCT07828236 |
Lm-LLO-TT and Gemcitabine in Unresectable Pancreatic Ductal Adenocarcinoma |
| NCT07587229 |
Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer |
| NCT04191551 |
The GAstric Precancerous Conditions Study |
| NCT07220239 |
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome |
| NCT04861077 |
Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI) |
| NCT07813637 |
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC |
| NCT07649057 |
A Study of a Urine Test to Detect Colorectal Cancer |
| NCT01834001 |
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy |
| NCT05625529 |
ExoLuminate Study for Early Detection of Pancreatic Cancer |
| NCT07401381 |
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer |
| NCT07262138 |
Active Surveillance in Older Women With ER+ Breast Cancer |
| NCT06626516 |
Tebentafusp-tebn With LDT in Metastatic UM |
| NCT06203106 |
NYSCF Scientific Discovery Biobank |
| NCT06158139 |
Autologous CAR-T Cells Targeting B7-H3 in PDAC |
| NCT07148128 |
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. |
| NCT07282158 |
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians |
| NCT03842943 |
Neoadjuvant Combination Immunotherapy for Stage III Melanoma |
| NCT07564141 |
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer |
| NCT06040970 |
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer |
| NCT05386108 |
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer |
| NCT07198074 |
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer |
| NCT07454603 |
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth |
| NCT05692024 |
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER |
| NCT06966388 |
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation |
| NCT05454488 |
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer |
| NCT06545942 |
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors |
| NCT06235697 |
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment |
| NCT07488923 |
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1) |
| NCT06411691 |
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer |
| NCT05056818 |
Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics |
| NCT07541079 |
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer) |
| NCT04765150 |
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification |
| NCT07504796 |
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab |
| NCT05746182 |
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms |
| NCT03396341 |
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes |
| NCT06896162 |
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival |
| NCT06638294 |
Study in Patients With Breast Cancer Leptomeningeal Metastasis |
| NCT07833566 |
Biopsy-site-marker in Breast Cancer |
| NCT05620329 |
UNC Pleural Fluid Registry |
| NCT06200259 |
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement |
| NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
| NCT04222413 |
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors |
| NCT06478589 |
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors |
| NCT04074720 |
Prospective Breast Cancer Biospecimen Collection |
| NCT07040891 |
A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials |
| NCT05384535 |
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort |
| NCT05150691 |
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors |
| NCT07211659 |
Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients |
| NCT04799535 |
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring |
| NCT04588025 |
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response |
| NCT06931340 |
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial |
| NCT06607458 |
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease |
| NCT07832617 |
Protoacoustic Imaging For 3D Mapping |
| NCT07001748 |
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity |
| NCT06610825 |
Castrate Resistant Prostate Cancer Enhertu Therapy |
| NCT01638676 |
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients |
| NCT06536374 |
Folate Study in Men With Advanced Prostate Cancer |
| NCT06946225 |
ACTengine® IMA203 Combined With mRNA-4203 |
| NCT06981208 |
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction |
| NCT07805954 |
Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma |
| NCT06728072 |
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer |
| NCT05176483 |
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors |
| NCT07335354 |
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery |
| NCT07261631 |
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors |
| NCT06073431 |
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia |
| NCT07283939 |
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays |
| NCT06165419 |
Definitive Radiation for High-Risk Spine Metastases |
| NCT05915442 |
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer |
| NCT04970056 |
Pancreatic Cancer Early Detection Consortium |
| NCT05316129 |
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer |
| NCT07407920 |
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial |
| NCT04683679 |
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer |
| NCT06176261 |
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs |
| NCT05006131 |
Pancreatic Cancer Screening for At-risk Individuals |
| NCT05890677 |
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema |
| NCT07201519 |
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy |
| NCT05812807 |
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab |
| NCT07875192 |
Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting |
| NCT06666790 |
DermaSensor Postmarket Surveillance Study |
| NCT05654246 |
Susan G. Komen's ShareForCures |
| NCT06067269 |
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial |
| NCT07205822 |
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer |
| NCT05758688 |
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer |
| NCT06030622 |
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer |
| NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
| NCT07768436 |
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer |
| NCT05462496 |
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer |
| NCT06264180 |
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3] |
| NCT05803382 |
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers |
| NCT07824583 |
A Study Evaluating a New Radiation Treatment Workflow (NGDS) |
| NCT06953245 |
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy |
| NCT06666439 |
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer |
| NCT06058377 |
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer |
| NCT07690579 |
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities |
| NCT06635980 |
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer |
| NCT07069712 |
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma |
| NCT07685249 |
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment |
| NCT07748208 |
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes |
| NCT05428735 |
The DRAGON 2 Trial |
| NCT07189403 |
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer |
| NCT04945642 |
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma |
| NCT07237269 |
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer |
| NCT07148245 |
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma |
| NCT07545811 |
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer |
| NCT07403981 |
Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients |
| NCT05989828 |
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer |
| NCT05765500 |
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life |
| NCT07029490 |
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study |
| NCT04586959 |
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer |
| NCT07643012 |
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer |
| NCT03556228 |
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma |
| NCT07348367 |
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers. |
| NCT06366490 |
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer |
| NCT06807359 |
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System |
| NCT07224724 |
Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases |
| NCT06907446 |
Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies |
| NCT07389239 |
A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. |
| NCT07535112 |
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation |
| NCT07779967 |
Alcohol, Breast Cancer, and Metabolism |
| NCT06139107 |
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole |
| NCT07227168 |
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer |
| NCT07468903 |
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer |
| NCT05687123 |
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors |
| NCT03785288 |
Vaginal Cuff Brachytherapy Fractionation Study |
| NCT07554560 |
Nutrition Intervention for Pancreatic Cancer |
| NCT05136196 |
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study |
| NCT06541210 |
Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men |
| NCT06353997 |
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients |
| NCT05384496 |
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma |
| NCT07109817 |
Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer |
| NCT05935384 |
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation |
| NCT06260033 |
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer |
| NCT06414733 |
HER-2 B Cell Peptide Vaccine |
| NCT07427043 |
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES) |
| NCT06401889 |
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy |
| NCT03492671 |
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer |
| NCT06562192 |
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers |
| NCT07690917 |
A Study of a New PET Scanner in People With Cancer |
| NCT04700332 |
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer |
| NCT03054584 |
Genetic Basis of Melanocytic Nevi |
| NCT07478185 |
Prehab for Pancreatic Cancer Surgery |
| NCT04751435 |
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients |
| NCT04778449 |
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma |
| NCT05696626 |
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation |
| NCT07223047 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies |
| NCT04048278 |
Lidocaine Infusion in Pancreatic Cancer |
| NCT07509008 |
Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum |
| NCT06580314 |
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer |
| NCT06780176 |
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida |
| NCT07830225 |
A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma. |
| NCT07361614 |
Pilot Testing of a Colorectal Cancer Education Program |
| NCT06887205 |
Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study |
| NCT07184970 |
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound |
| NCT06626022 |
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging. |
| NCT07278986 |
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer |
| NCT05000294 |
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types |
| NCT04360330 |
SABER Study for Selected Early Stage Breast Cancer |
| NCT03606967 |
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer |
| NCT07227636 |
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy |
| NCT06128551 |
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors |
| NCT02610439 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer |
| NCT06806930 |
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) |
| NCT06070012 |
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma |
| NCT07553234 |
Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment |
| NCT07647328 |
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer |
| NCT06044857 |
PSMA PET Response Guided SabR in High Risk Pca |
| NCT06072612 |
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. |
| NCT05873192 |
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer |
| NCT07136181 |
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma |
| NCT07631000 |
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer |
| NCT06757192 |
CRC Screening in Unscreened Individuals 45-54 |
| NCT07386444 |
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy |
| NCT07675967 |
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study |
| NCT02478892 |
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk |
| NCT04523857 |
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer |
| NCT07120100 |
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors |
| NCT07144228 |
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer |
| NCT04513028 |
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma |
| NCT04606030 |
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) |
| NCT00353483 |
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells |
| NCT06481592 |
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. |
| NCT07578571 |
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer |
| NCT07778498 |
A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors. |
| NCT06168487 |
Telmisartan in Prostate Cancer |
| NCT06785636 |
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC |
| NCT06648434 |
MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT07020221 |
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors |
| NCT04221893 |
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers |
| NCT01900821 |
National Mammography Database |
| NCT05854498 |
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer |
| NCT05208762 |
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors |
| NCT07551596 |
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial |
| NCT06559059 |
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs |
| NCT07578649 |
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer |
| NCT06314958 |
Stage II/III Colorectal Cancer Recurrence |
| NCT07215000 |
Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial |
| NCT07513311 |
A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer |
| NCT07125209 |
Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers |
| NCT07136428 |
Asciminib in HER2+ Breast Cancer Brain Metastases |
| NCT05636111 |
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer |
| NCT05366881 |
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease |
| NCT07137871 |
Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy |
| NCT06801236 |
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT06888388 |
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer |
| NCT04410302 |
Patient-Derived Xenografts to Reduce Cancer Health Disparities |
| NCT05398302 |
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy |
| NCT05013255 |
Pioglitazone Therapy Targeting Fatigue in Breast Cancer |
| NCT04373564 |
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years |
| NCT04526587 |
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors |
| NCT06922318 |
The COSMYC Trial (COmbined Suppression of MYC) |
| NCT07254910 |
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma |
| NCT06957691 |
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy |
| NCT05123482 |
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies |
| NCT07224425 |
A Study of BI 3810944 in Patients With Advanced Cancer |
| NCT06040125 |
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial |
| NCT06708429 |
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System |
| NCT06802172 |
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial |
| NCT05020574 |
Microbiome and Association With Implant Infections |
| NCT04339374 |
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer |
| NCT03784924 |
EDRN Prostate MRI Biomarker Study |
| NCT05863195 |
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial |
| NCT05998135 |
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer |
| NCT06413680 |
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body |
| NCT04150042 |
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells |
| NCT05627960 |
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies |
| NCT05447923 |
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities |
| NCT05274048 |
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients |
| NCT07318389 |
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer |
| NCT06451497 |
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors |
| NCT07361562 |
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors |
| NCT07225946 |
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT05483283 |
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care |
| NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
| NCT06605430 |
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer |
| NCT06940271 |
Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy |
| NCT04794322 |
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer |
| NCT07417488 |
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas |
| NCT07823322 |
A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy |
| NCT05764720 |
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach |
| NCT06826924 |
7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer |
| NCT05092373 |
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax |
| NCT07127003 |
ILR to Prevent BRCL_MCC 23608 |
| NCT07634380 |
Sitagliptin With Pembro in RCC and Melanoma |
| NCT05630794 |
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201 |
| NCT07426913 |
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab |
| NCT03692429 |
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells |
| NCT07652242 |
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer |
| NCT06727773 |
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer |
| NCT06745895 |
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening |
| NCT06989437 |
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue |
| NCT07677839 |
UHFUS Characterization of Normal Lymphatic Anatomy |
| NCT03161522 |
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer |
| NCT05349227 |
Comprehensive Outcomes for After Cancer Health |
| NCT01102556 |
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease |
| NCT03492151 |
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions |
| NCT05491226 |
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation |
| NCT06998940 |
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations |
| NCT04913285 |
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors |
| NCT07327489 |
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) |
| NCT07645391 |
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer |
| NCT07890415 |
Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis |
| NCT07434817 |
Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment |
| NCT04475640 |
Cancer Genetic Testing in Ethnic Populations |
| NCT05503797 |
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations |
| NCT06956690 |
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors |
| NCT06915025 |
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer |
| NCT07405476 |
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment |
| NCT05879926 |
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 |
| NCT03259867 |
Combination of TATE and PD-1 Inhibitor in Liver Cancer |
| NCT07213609 |
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors |
| NCT03354416 |
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer |
| NCT05877599 |
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation |
| NCT07296887 |
CARE Tool Study Aim 3 |
| NCT05280314 |
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors |
| NCT05983432 |
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors |
| NCT04918186 |
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer |
| NCT05422794 |
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer |
| NCT06984562 |
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer |
| NCT06052488 |
Strength After Breast Cancer |
| NCT06179303 |
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer |
| NCT07044583 |
SAVE Trial: SAfe Opioid Use Video Education |
| NCT07804186 |
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma |
| NCT06800105 |
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study |
| NCT00040352 |
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma |
| NCT04370587 |
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors |
| NCT05720338 |
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy? |
| NCT03823144 |
Intravital Microscopy in Human Solid Tumors |
| NCT06425926 |
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors |
| NCT01954992 |
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer |
| NCT06141993 |
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials |
| NCT06225011 |
Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer |
| NCT07487844 |
Pulsed Electric Field Ablation for Metastatic Breast Cancer |
| NCT07213804 |
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer |
| NCT07504835 |
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer |
| NCT02775643 |
Molecular Analysis of Childhood and Adolescent Melanocytic Lesions |
| NCT07930182 |
Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring |
| NCT05373823 |
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors |
| NCT06937996 |
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System- |
| NCT07553390 |
Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers |
| NCT04636710 |
Refining Local-Regional Therapy for IBC |
| NCT06441890 |
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer |
| NCT07612215 |
Elacestrant in Advanced Triple Positive Breast Cancer |
| NCT06548789 |
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED |
| NCT07505797 |
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health |
| NCT07818018 |
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma |
| NCT05187182 |
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer |
| NCT06518746 |
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation |
| NCT05287451 |
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study |
| NCT06194929 |
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma |
| NCT05770531 |
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy |
| NCT07550088 |
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases |
| NCT07166042 |
Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies |
| NCT06807437 |
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula |
| NCT03990896 |
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial |
| NCT07286331 |
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01) |
| NCT04406831 |
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer |
| NCT04701645 |
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer |
| NCT06750094 |
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy |
| NCT06543537 |
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer |
| NCT06362369 |
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy |
| NCT05774951 |
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy |
| NCT07546331 |
Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction |
| NCT06066437 |
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial |
| NCT07199764 |
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer |
| NCT05919264 |
FOG-001 in Locally Advanced or Metastatic Solid Tumors |
| NCT07162337 |
BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention |
| NCT06663319 |
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers |
| NCT07476001 |
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC |
| NCT05315700 |
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration |
| NCT02328677 |
ColoCare Study - Colorectal Cancer Cohort |
| NCT02870244 |
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes |
| NCT07619534 |
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases |
| NCT05929768 |
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer |
| NCT06276491 |
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors |
| NCT05239546 |
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers |
| NCT05625659 |
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts |
| NCT06503146 |
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection |
| NCT07288359 |
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors |
| NCT07555210 |
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy |
| NCT07776613 |
A Study of Romosozumab in People With Breast Cancer and Osteoporosis |
| NCT01766297 |
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer |
| NCT07751159 |
Radiation Therapy Approaches for People With Prostate Cancer |
| NCT04946370 |
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer |
| NCT06388122 |
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients |
| NCT06997029 |
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors |
| NCT06085313 |
Cancer Pain Management Using a Web-based Intervention |
| NCT04751396 |
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors |
| NCT07181473 |
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors |
| NCT05652686 |
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) |
| NCT05803941 |
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
| NCT06295159 |
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma |
| NCT05304962 |
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer |
| NCT07450859 |
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) |
| NCT05864196 |
Two Fraction Prostate SBRT With DIL SIB |
| NCT06504147 |
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery |
| NCT06855706 |
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study |
| NCT07500298 |
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer |
| NCT06999798 |
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial |
| NCT06205849 |
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer |
| NCT05052671 |
ctDNA Assay in Patients With Resectable Pancreatic Cancer |
| NCT06434064 |
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer |
| NCT04516447 |
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer |
| NCT07059884 |
Distance-Based Exercise to Preserve Function and Prevent Disability |
| NCT06293898 |
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors |
| NCT06856694 |
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer |
| NCT03451383 |
Older Breast Cancer Patients: Risk for Cognitive Decline |
| NCT05629494 |
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test |
| NCT04994067 |
Intra-Operative Radiation Registry |
| NCT06084416 |
A Study of Sovilnesib in Subjects With Ovarian Cancer |
| NCT06257693 |
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer |
| NCT07912593 |
A KRAS Inhibitor in Participants With Advanced Solid Tumors |
| NCT07770100 |
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) |
| NCT05295407 |
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy |
| NCT07739563 |
EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer |
| NCT07621614 |
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information |
| NCT06568016 |
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers |
| NCT05902507 |
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer |
| NCT03448926 |
The PREDICT Registry: |
| NCT04074135 |
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors |
| NCT05074290 |
Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients |
| NCT07345676 |
Colorectal Cancer Screening Outreach |
| NCT07832292 |
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer |
| NCT07107334 |
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia |
| NCT06582615 |
Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer |
| NCT05593497 |
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss |
| NCT05984589 |
Personalized Health Self-Management Training for Colorectal Cancer Survivors |
| NCT07224789 |
Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA |
| NCT07379138 |
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients |
| NCT06252649 |
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation |
| NCT05505643 |
Cryoablation vs Lumpectomy in T1 Breast Cancers |
| NCT07851025 |
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer |
| NCT04567771 |
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer |
| NCT06876714 |
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab |
| NCT04844528 |
Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers |
| NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. |
| NCT07217704 |
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. |
| NCT06605404 |
Pan-tumor MRD Study |
| NCT07126158 |
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma |
| NCT07216248 |
Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer |
| NCT05780684 |
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer |
| NCT05242744 |
FTT PET/CT in Metastatic Prostate Cancer |
| NCT07050771 |
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery |
| NCT02997293 |
Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery |
| NCT06195306 |
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction |
| NCT07284849 |
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer |
| NCT05789433 |
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer |
| NCT05592626 |
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors |
| NCT06161506 |
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer |
| NCT07455058 |
Water Vapor Ablation for Prostate Cancer: Long-Term Registry |
| NCT05379985 |
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS |
| NCT07066189 |
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC |
| NCT06112314 |
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) |
| NCT07529808 |
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma |
| NCT06364410 |
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors |
| NCT06674863 |
Addressing Health Literacy With a Tailored Survivorship Care Plan |
| NCT06683755 |
Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY) |
| NCT03322891 |
Improving Health Literacy in African-American Prostate Cancer Patients |
| NCT05805436 |
Preop Laxatives in Robotic Urologic Surgery |
| NCT05142800 |
Screening For BCRL In Targeted Therapy For Breast Cancer |
| NCT07278336 |
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer |
| NCT07416552 |
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC) |
| NCT04348747 |
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer |
| NCT04472338 |
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study |
| NCT07814248 |
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors |
| NCT06401421 |
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) |
| NCT06888102 |
A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer |
| NCT07383649 |
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection |
| NCT06405828 |
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer |
| NCT07644598 |
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer |
| NCT05323409 |
Improving Comprehensive Care of Cancer Patients |
| NCT06423963 |
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer |
| NCT07406087 |
Navigation Intervention for Adolescent and Young Adult Cancer Survivors |
| NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
| NCT06067841 |
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer |
| NCT07124611 |
A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer |
| NCT06460298 |
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer |
| NCT07069556 |
ColoSense Post-Approval Study |
| NCT05952453 |
Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro |
| NCT04557969 |
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis |
| NCT06785441 |
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing |
| NCT07227831 |
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer |
| NCT03151629 |
International Registry for Men With Advanced Prostate Cancer (IRONMAN) |
| NCT03933670 |
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance |
| NCT06262139 |
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients |
| NCT03608631 |
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation |
| NCT06789653 |
A Novel Approach Utilizing Organ Specific Age Proteomics |
| NCT07059845 |
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer |
| NCT07553572 |
Remote Monitoring and Symptom Management Digital Application |
| NCT05490472 |
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors |
| NCT03769766 |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance |
| NCT05496829 |
IMPACT Trial: Intervention to iMProve AdherenCe Equitably |
| NCT06369246 |
PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer. |
| NCT06654037 |
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer |
| NCT07612046 |
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening |
| NCT06738303 |
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer |
| NCT07235293 |
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. |
| NCT05519449 |
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) |
| NCT02422641 |
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis |
| NCT07142551 |
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response |
| NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
| NCT05026983 |
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases |
| NCT06236139 |
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT07206121 |
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery |
| NCT06450106 |
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy |
| NCT07460752 |
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients |
| NCT07071038 |
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients |
| NCT04473794 |
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts |
| NCT07543757 |
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix |
| NCT06423326 |
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer |
| NCT02620852 |
Women Informed to Screen Depending on Measures of Risk (Wisdom Study) |
| NCT06948448 |
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer |
| NCT07730021 |
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors |
| NCT06730347 |
A Study of Lorigerlimab in Participants With Advanced Solid Tumors |
| NCT07213791 |
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors |
| NCT07746713 |
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer |
| NCT06903468 |
Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions |
| NCT06515613 |
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors |
| NCT04489238 |
Collection of Information to Better Understand Young Onset Colorectal Cancer |
| NCT07906717 |
A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer |
| NCT06864338 |
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test |
| NCT05592938 |
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) |
| NCT06833255 |
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York |
| NCT03769415 |
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA |
| NCT07624617 |
Fast-Her: Fasting Effects on Breast Cancer Treatment |
| NCT07444606 |
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases |
| NCT05501704 |
ETHAN - ET for Male BC |
| NCT06288113 |
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial |
| NCT07618273 |
Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial |
| NCT07572162 |
Post-market Safety Study of LUMISIGHT |
| NCT06887218 |
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer |
| NCT05568550 |
Pembro With Radiation With or Without Olaparib |
| NCT07215988 |
Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study |
| NCT07527143 |
Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer |
| NCT07593079 |
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer |
| NCT07281924 |
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis |
| NCT05142033 |
Avera Cancer Sequencing and Analytics Protocol (ASAP) |
| NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
| NCT07228000 |
Bundled Cancer Screening and Genetic Services Navigation |
| NCT06723236 |
A Study of MGC028 in Participants With Advanced Solid Tumors |
| NCT06305299 |
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells |
| NCT06581406 |
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma |
| NCT05245500 |
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion |
| NCT06830265 |
Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis |
| NCT03833921 |
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer |
| NCT07444814 |
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors |
| NCT07622901 |
Fasting InTervention for Endometrial Cancer |
| NCT05607095 |
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma |
| NCT07500012 |
taVNS for Breast Cancer Pain and Symptom Management |
| NCT06084481 |
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 |
| NCT06172283 |
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy |
| NCT07189195 |
TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma |
| NCT07332975 |
ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC |
| NCT07173751 |
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer |
| NCT07102381 |
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer |
| NCT06731894 |
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors |
| NCT03538665 |
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons |
| NCT04857502 |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer |
| NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
| NCT06855654 |
Promoting Resilience in Women With Breast Cancer (PRISM -MBC) |
| NCT06171139 |
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer |
| NCT07764796 |
Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya |
| NCT05804370 |
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) |
| NCT06789172 |
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors |
| NCT06705686 |
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer |
| NCT05926102 |
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) |
| NCT07006727 |
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors |
| NCT07765927 |
Exercise Oncology Clinic Pilot Feasibility Trial |
| NCT07322094 |
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer |
| NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
| NCT05795101 |
TRUDI: TDXD+Durva in HER2+/Low IBC |
| NCT05896839 |
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer |
| NCT07405801 |
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer |
| NCT06496256 |
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial |
| NCT07226427 |
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer |
| NCT06774027 |
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer |
| NCT07018986 |
The MIND-BC Study: MIND Diet for Breast Cancer Cognition |
| NCT06217822 |
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) |
| NCT04429542 |
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors |
| NCT04616131 |
Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy |
| NCT07294703 |
Factors Associated With Breast Cancer Risks and Outcomes |
| NCT06022029 |
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. |
| NCT07909031 |
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors |
| NCT06636123 |
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy |
| NCT07109427 |
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System |
| NCT05974150 |
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring |
| NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
| NCT07226713 |
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors |
| NCT07487168 |
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors |
| NCT03877796 |
Clinical Pre-screening Protocol for Ovarian Cancer |
| NCT03564340 |
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers |
| NCT05659797 |
FES BPET-DBT in Newly Diagnosed Breast Cancer |
| NCT01042379 |
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer |
| NCT06318897 |
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer |
| NCT06710288 |
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer |
| NCT07677254 |
A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT07455903 |
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT |
| NCT05005403 |
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan |
| NCT07303894 |
A Study of Isoquercetin in People With Ovarian Cancer |
| NCT07725172 |
Radiation Therapy and Thymus Function in Young Women With Breast Cancer |
| NCT07535541 |
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007) |
| NCT04329494 |
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer |
| NCT06963905 |
Saci Nivo Rela for TNBC |
| NCT07179809 |
Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer |
| NCT04489719 |
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer |
| NCT04995198 |
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness |
| NCT06932757 |
Adjuvant Quisinostat in High-Risk Uveal Melanoma |
| NCT06666192 |
The Ohio State University (OSU) SCREEN Community Program |
| NCT04230109 |
Sacituzumab Govitecan In TNBC |
| NCT06111781 |
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer |
| NCT05366699 |
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy |
| NCT06591819 |
Hypofractionated WPPT With HDR Boost |
| NCT07114601 |
A Study of LY4257496 in Participants With Cancer (OMNIRAY) |
| NCT06063928 |
Confronting Cancer as a Community |
| NCT06336928 |
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis |
| NCT03723928 |
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer |
| NCT06251544 |
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer |
| NCT06638307 |
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer |
| NCT05588128 |
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL |
| NCT07158164 |
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment |
| NCT06934239 |
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients |
| NCT05187832 |
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer |
| NCT03449238 |
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients |
| NCT05830058 |
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma |
| NCT05766371 |
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer |
| NCT07227233 |
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer. |
| NCT05819892 |
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer |
| NCT07165132 |
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. |
| NCT06483048 |
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer |
| NCT06731998 |
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery |
| NCT07685938 |
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease |
| NCT04052048 |
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer |
| NCT07543055 |
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread |
| NCT06120283 |
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors |
| NCT07216495 |
Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC |
| NCT07646847 |
A Study of a Side Effects and Resource Navigation Program for People With Cancer |
| NCT07060807 |
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) |
| NCT06105749 |
Biennial CEM in Women With a Personal History of Breast Cancer |
| NCT06799065 |
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer |
| NCT07124000 |
DESTINY-PANTUMOUR04 |
| NCT06565052 |
The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial |
| NCT06898333 |
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening |
| NCT04678648 |
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies |